Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.

Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page has removed a citation for a study on Tislelizumab in Chinese patients with advanced solid tumors, which included an erratum reference.SummaryDifference0.3%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical study involving the anti-PD-1 monoclonal antibody BGB-A317 for advanced solid tumors. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference19%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.